Kantonsspital St.Gallen


Stefan Bilz, Andrea Räss & Victoria Grillmayr

abstract A randomized, double-blind, placebo-controlled, multi-Center Phase 2 study to assess the efficacy and safety of oral BAY 2327949 in patients with clinical diagnosis of chronic kidney disease due to diabetes or hypertension and at least one cardiovascular comorbidity
type of project clinical studies
status aborted
start of project 2020
end of project 2021
responsible person PD Dr. med. Stefan Bilz